O. Hiort et al., THE ROLE OF ANDROGEN RECEPTOR GENE-MUTATIONS IN MALE BREAST-CARCINOMA, The Journal of clinical endocrinology and metabolism, 81(9), 1996, pp. 3404-3407
Certain germline mutations (607Arg-Gln, 608Arg-Lys) in the androgen re
ceptor gene have been associated with the Occurrence of breast cancer
in males suffering from partial androgen insensitivity. To assess whet
her somatic mutations in this gene could be detected in breast carcino
ma, archival tumor tissue Of males without clinical evidence of androg
en insensitivity was screened for point mutations in the androgen rece
ptor gene. DNA was retrieved by chloroform-phenol extraction from form
alin-fixed, paraffin-embedded tissues. Exons 2-8 of the androgen recep
tor gene, encoding the DNA- and hormone-binding regions of the recepto
r, were amplified by polymerase chain reaction and subjected to noniso
topic single strand conformation assay (SSCA) to screen for point muta
tions. In the tumor DNA, no variations suggestive of mutations were en
countered on SSCA. However, in a control patient with partial androgen
insensitivity and predominantly female phenotype, the germline mutati
on 607Arg-Gln was identified in blood leukocyte DNA. Our results indic
ate that somatic mutations of the androgen receptor are not required f
or the development of male breast cancer. This, however, does not excl
ude an increased risk of breast carcinoma in patients with androgen in
sensitivity.